Navigation Links
Bluestar Silicones to Present Antimicrobial Silicones at Medical Silicones Conference in Boston
Date:9/27/2011

EAST BRUNSWICK, N.J., Sept. 27, 2011 /PRNewswire/ -- Bluestar Silicones Senior Scientist Dr. Olga Hoy, Ph.D., will present "Silicone Material to Control Bacterial Growth" at the upcoming Medical Silicones Conference in Boston, October 4-5.

According to Dr. Hoy, the rising number of hospital acquired infections, increasing cost of medical care and the aging population are factors that contribute to growing demand for medical devices and consumer goods that incorporate antimicrobial properties.

In her presentation, Dr. Hoy will explore the various factors medical device and consumer goods companies should consider in their quest for antimicrobial silicone materials.  From additive selection, to additive interaction with the silicone, to manufacturing process, to regulatory considerations, Dr. Hoy will demonstrate how a customized approach enables manufacturers to optimize the use of antimicrobials.

As a gold sponsor of the Medical Silicones Conference, Bluestar Silicones will host a tabletop display at the event highlighting its Silbione® brand adhesive silicone materials designed specifically for healthcare and medical applications.  For more information about Bluestar Silicones, call 1-866-474-6342.

About Dr. HoyDr. Olga Hoy is a senior scientist at Bluestar Silicones where she has been focused on antimicrobial silicones for the last 3 years.  She holds a Ph.D. in material sciences and engineering from Clemson University, Clemson, S.C., and an M.S. degree in pharmaceutical technology from Lviv Polytechnic National University, Lviv, Ukraine.

About Bluestar SiliconesWith worldwide operations headquartered in Lyon, France, Bluestar Silicones is a $650 million worldwide silicones raw material manufacturer.  Bluestar is one of the world's leading fully integrated global silicones manufacturers with more than 50 years of silicone expertise. Bluestar has manufacturing operations throughout the world and offers a comprehensive range of silicone technologies in support of diverse specialty markets including paper release, textile coatings, healthcare, moldmaking, automotive, aerospace and personal care.  For more information, call (866) 474-6342 or visit www.bluestarsilicones.com.Press Contact: Karen O'Keefe, (732) 227-2089karen.okeefe@bluestarsilicones.com
'/>"/>

SOURCE Bluestar Silicones
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bluestar Silicones Introduces its New Silbione(R) Products for Healthcare at MEDICA 2010 in Dusseldorf
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
6. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
9. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
10. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
11. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... LONDON , January 18, 2017 ... community to share research resources, has opened its first North ... . ... This marks an expansion for Ximbio following its launch in ... Cancer Research Technology (CRT), the commercialization arm of the foundation ...
(Date:1/18/2017)... 2017 After the recent election cycle, ... of cannabis both for medical and recreational purposes are shifting. ... to the use of cannabis, but the focus is coming ... Market Research, the North American legal cannabis market posted $6.7 ... year. The research projects sales will grow at a compound ...
(Date:1/18/2017)... , Jan. 18, 2017  Astellas Pharma Inc. ... ) today announced its participation in Access Accelerated, ... non-communicable disease (NCD) prevention, diagnostics and treatment in ... other leading pharmaceutical companies and in collaboration with ... International Cancer Control (UICC), Astellas will work towards ...
Breaking Medicine Technology:
(Date:1/17/2017)... York, NY (PRWEB) , ... January 17, 2017 , ... ... grand opening of a new showroom at South Dixie Hwy in Miami, FL. , ... Officer at Gym Source. “The new innovative in-store concept is designed to give clients ...
(Date:1/17/2017)... ... ... For breast cancer clinicians and researchers who were unable to attend the ... review and analysis of its highlights, a novel half-day, complimentary meeting—the 14th Annual Best ... February 4, 2017 in Chicago. Chaired by Kathy S. Albain, MD, FACP, FASCO from ...
(Date:1/17/2017)... ... January 17, 2017 , ... Healthful Balance announces ... company, owned and operated by Ed Stroup, was created to offer the highest ... highest level of customer service. Healthful Balance products can be purchased online through ...
(Date:1/17/2017)... Petersburg, Florida (PRWEB) , ... January 17, 2017 , ... ... the Producers of AsSeenOnTV.pro will be featuring DRTV campaigns regarding the topic of Beauty ... to become a better version of themselves. What better way to commit to these ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... century approach to infusing high speed technology into the fabric of an entire ... the advancement of healthcare and wellness in a yet-to-be-named, health focused campus. Leading ...
Breaking Medicine News(10 mins):